Umbilical hernia prosthesis

Abstract
The present invention relates to a prosthesis (200) comprising: —one mesh (1) delimited by a peripheral exterior edge (1a), —a frame (2) fastened to said mesh and adopting the shape of said peripheral exterior edge of the mesh, said frame being set back from said peripheral exterior edge and being provided with two hinge points (3a, 3b), the line passing through said two hinge points also passing through the centre (1b) of the mesh and thus forming a line M for folding the mesh in two, characterized in that said prosthesis further comprises at least two anchor pieces (5) made of suturable material and located on a single face of the mesh (1) on either side of said folding line, each piece having a fixed part (5a) linked to said mesh and a free part (5b), said free part being linked to at least one thread-shaped element (7).
Description

The present invention provides a prosthesis, for repairing hernias, for example, comprising a mesh and a member for reinforcing the mesh.


In humans the abdominal wall consists of fat and muscles interconnected by aponeuroses. A break in continuity may occur at the level of the aponeuroses, allowing part of the peritoneum to pass through and form a sac, known as a hernia, containing either fat or a portion of the intestine. Hernias or ventral ruptures (hernias occurring on a parietal surgical scar) are manifested by a protrusion on the surface of the skin and are called umbilical or inguinal hernias or ventral ruptures, for example, as a function of their location.


To repair a hernia, surgeons often fit a synthetic mesh prosthesis that replaces or reinforces the weakened anatomical tissue.


However, the efficacy of the prosthesis, and thus minimizing the risk of relapse, depend to a great degree on the proper fixing of the prosthesis. In particular, before being fixed, the prosthesis must be correctly spread over the abdominal wall that it is intended to reinforce. Prostheses of mesh type, i.e. based on an arrangement of threads forming a textile, are generally flexible, and to introduce them into the hernia they are often folded to reduce their volume. They therefore tend to form creases on the abdominal wall when they are introduced onto the implantation site. In this respect spreading them out is of primary importance but may prove difficult, in particular in the case of treating an umbilical hernia, which, being smaller than an inguinal hernia, offers little working space and little visibility for manipulation of the prosthesis by the surgeon.


In the case of umbilical hernias, for example, or when the aim of treatment is to repair trocart holes or preventive, the size of the defect to be treated is small, for example from 1 to 4 cm diameter, and open surgery may be envisaged without widening the defect. However, in this type of surgery, the surgeon has little working space and little visibility. It would thus be preferable to have a prosthesis that is easy to position, to spread out and to fix, if possible avoiding the necessity for sutures at the periphery of the prosthesis, which is complicated and laborious under such working conditions.


Failure to spread the prosthesis out perfectly against the abdominal wall leads to the risk of trapping the peritoneal sac and the risk of insertion of a soft organ between the prosthesis and the abdominal wall, which can lead to the risk of adhesions, pain and intestinal blockage and increase the possibility of relapse. It is therefore essential for the surgeon to be sure that no part of the prosthesis remains folded and that no viscera or any part of the intestines lie between the prosthesis and the abdominal wall. Moreover, incorrect positioning of the sutures or incorrect fixing of the prosthesis risks distortion of the prosthesis and the creation of tensions.


Thus in the case of an umbilical hernia in particular, having a small orifice for introducing the prosthesis, it would be beneficial to have a prosthesis adapted to occupy a small volume in a first configuration in order to facilitate its introduction into the abdominal cavity via said orifice and then to be deployed, spread out and pressed easily against the abdominal wall so that the surgeon is sure of the optimal positioning of the prosthesis and can moreover fix the prosthesis efficaciously without sutures at its periphery, and this, despite the little intrinsic visibility of small size hernias.


Various prostheses that may be folded up and then deployed are available.


The present invention concerns a prosthesis that is adapted to be folded up in order to reduce the volume that it occupies at the time of its introduction into a small incision and on the other hand to be spread out and fixed easily so that the surgeon is sure of the perfect spreading of the prosthesis and that it may be fixed efficaciously at a certain distance between the centre of the prosthesis and its periphery without sutures at the periphery of the prosthesis and this, despite the little intrinsic visibility of small size hernias.


The prosthesis of the invention is beneficial for treating hernias of the abdominal wall, in particular for treating umbilical hernias where the defect is small.


A first aspect of the present invention provides a prosthesis comprising:

    • at least one flexible mesh delimited by a peripheral exterior edge,
    • at least one member for reinforcing said mesh, said reinforcing member taking the form of a frame fastened to said mesh and substantially adopting the shape of said peripheral exterior edge of the mesh, said frame being set back from said peripheral exterior edge and being provided with two hinge points, the line passing through said two hinge points also passing through the centre of the mesh and thus forming a line M for folding the mesh in two,
    • characterized in that said prosthesis further comprises at least two anchor pieces made of suturable material and located on a single face of the mesh on either side of said folding line, each piece having a fixed part linked to said mesh and a free part, said free part being linked to at least one thread-shaped element.


The reinforcing member or frame may be rigid or have some flexibility. According to the present invention, the mesh and thus the prosthesis can be folded in two because of the presence of the two hinge points of the frame, regardless of the presence or not of intrinsic elastic properties of the frame.


In the context of the present application the term “mesh” refers to an arrangement of biocompatible threads, for example a knitted, woven or non-woven material, preferably of the openwork kind, i.e. having pores encouraging tissue recolonization. Such a mesh may be bioresorbable, partly bioresorbable or permanent. It is sufficiently flexible to be folded up at the time of its introduction into the abdominal cavity. The mesh may be produced from one layer of textile or from a plurality of layers of textiles. Such meshes are well known to the person skilled in the art. The mesh usable for the invention may be supplied in any shape (rectangular, square, circular, oval, etc.) and then cut to match the shape of the hernia defect. For example, the mesh may have the overall shape of a disc or an oval: in this case the frame also has a circular or oval shape and is preferably in the form of a ring. Alternatively, the mesh may have a globally square or rectangular shape: in this case the frame also has a square or rectangular shape. The frame is set back from the exterior peripheral edge of the mesh: thus, whilst adopting the shape of the contour of the mesh, the frame has an exterior perimeter smaller than that of the exterior peripheral edge of the mesh: in other words, the exterior peripheral edge of the mesh extends a certain distance beyond the frame. This distance may be greater than or equal to 1 mm, for example. In other words also, the frame and the exterior peripheral edge of the mesh are of similar geometric shape but the frame shows dimensions which are less than that of the exterior peripheral edge of the mesh.


As will become apparent from the following description, the shape of the frame and its location, set back slightly from the exterior peripheral edge of the mesh, enable the surgeon, when implanting the prosthesis, to fix it to the peritoneum efficaciously without requiring sutures at the periphery of the mesh: the surgeon is able to fix the prosthesis along the interior contour of the frame only, said interior contour defining a stitches fixing line: this avoids the surgeon having to apply stitches to the prosthesis at the exterior peripheral edge of the mesh, which is difficult to reach and hardly visible because of the small size of the incision. The interior contour of the frame of the prosthesis of the invention defines a fixing line, or stitching line, located approximately half way between the centre of the mesh and its exterior peripheral edge, along which the surgeon may locate the stitches when he fixes the prosthesis to the abdominal wall. Nevertheless, perfect spreading out of the prosthesis is assured by the presence of the frame which, by adopting the shape of the contour of the exterior peripheral edge, ensures deployment of the prosthesis and pressing thereof onto the abdominal wall.


In the context of the present application, by “anchor piece made of suturable material” is meant that the anchor piece is capable of being linked to, or passed through by, a thread-shaped element as defined in the present application, without being torn off when a user, such as a surgeon for example, exerts a moderate tension on said thread-shaped element, such as the necessary tension for orientating and/or positioning the prosthesis in the implantation site, as described hereinafter. Thus the anchor piece may be under the form of a textile, either knitted, woven or nonwoven, open worked or not; alternatively or in addition, the anchor piece may be under the form of a film or a sheet of material, as long as this textile, film and/or sheet of material is not torn off under the effect of the moderate tension as described above exerted on a thread-shaped element linked to, or passing through, said textile, film and/or sheet.


The anchor pieces may be made of bioresorbable material or not. The bioresorbable material may be chosen, for example, from polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), oxidized cellulose, polyglycol acid (PGA), copolymers of these materials and mixtures thereof.


As will be apparent from the following description, the anchor pieces are useful to the surgeon for facilitating the positioning of the prosthesis in the centre of the defect to be treated, and for attaching the prosthesis to the biological tissues. The anchor pieces also form the parts of the prosthesis by which said prosthesis is sutured to the abdominal wall.


The anchor pieces of the prosthesis of the invention are located on one single face of the mesh: as will be apparent from the following description, the anchor pieces are located on the face of the mesh intended to face the abdominal wall once the prosthesis is implanted: indeed, said anchor pieces are intended to be reached by the surgeon through the incision made for the implantation, in particular by means of thread-shaped elements, in view of assisting the surgeon to orientate and position the prosthesis as well as to raise the edges of the hernia defect for visualising the area to be stitched, when the prosthesis is put in place. The prosthesis of the invention thus comprises at least two anchor pieces located on either side of the folding line, preferably at two places which are symmetrical to each other with respect to this folding line: such a location of the anchor pieces enables the surgeon to expand the prosthesis optimally when it is put in place. According to the invention, the number of anchor pieces is not limited and the prosthesis may comprise 3 or 4 anchor pieces, even more. Each anchor piece shows a fixed part linked to the mesh of the prosthesis, and a free part, not attached to the mesh, and forming a type of shutter, flap or flying part. The fixed part of the anchor piece may be linked to the mesh by gluing, welding, sewing or by any biocompatible fixing means. In one embodiment, the anchor pieces are linked to the mesh via their fixed part by means of the reinforcing member.


The anchor pieces may show any geometrical shape. They may be identical or different.


In one embodiment, each anchor piece having a geometrical shape with at least one side having a length equal or greater than that of the other sides, each anchor piece is linked to the mesh by its longest side, along a direction perpendicular to the segment linking the centre of the mesh and the point of fixation of said piece in the plane of the mesh. In such an embodiment, each anchor piece being linked to the mesh by its longest side, the free part, or shutter or flap of each piece occupies only little space in the surroundings of the mesh: this enables maintaining a clear and non obstructed space around the hernia defect when the prosthesis is put in place and therefore allows the surgeon having a good visibility of the implantation site and not being impeded by the presence of useless extra elements. Such an embodiment also enables a more secure fixation of the anchor pieces to the mesh. Moreover, the positioning of the anchor pieces, i.e. along a direction perpendicular to the segment linking the centre of the mesh and the point of fixation of said piece in the plane of the mesh, allows the surgeon to position the prosthesis optimally by pulling on the thread-shaped elements linked to the anchor pieces in a centrifugal direction with respect to the hernia defect, as will be apparent in the following description.


In one embodiment, the suturable material is a textile and the anchor pieces are textile pieces. This textile may be identical to that of the mesh, or different. For example, the anchor pieces may be sewn to the mesh.


In the context of the present application, by “thread-shaped element”, is meant a flexible and elongated element, the length of which is much more greater than its thickness and its width, the contour of the cross section of which is globally circular: examples of thread-shaped elements of the invention may be a thread on its own, composite or not, or several threads, for example arranged together to make a braid, a tube, and combinations thereof. In embodiments, the thread-shaped elements are selected from threads, flexible tubes and combinations thereof.


In the prosthesis of the invention, the free part of each anchor piece is linked to at least one thread-shaped element. As will be apparent from the detailed description below, the thread-shaped element is intended to allow the surgeon to pull on the anchor piece linked thereto in order to expand, orientate and position the prosthesis when said prosthesis is put in place: preferably, the surgeon will pull simultaneously on the thread-shaped elements of the at least two anchor pieces which are present in order to counterbalance the prosthesis with respect to the defect to be treated. In addition, due to its structure, the thread-shaped element does not unnecessarily encumber the working area for the surgeon, said area being already naturally particularly limited regarding small size hernias.


In embodiments, the thread-shaped elements are flexible tubes: because of their hollow structure, necessitating a certain outer diameter, for example equal or greater than 3 mm, the tubes show a quite important outer surface capable of being in contact with the margins of the defect, this allowing decreasing dramatically the potential traumatic effect due to the contact of the tubes with the margins of the defect. The flexibility of the tubes allows their easy handling with no risk of damaging the tissues. Preferably, the tubes are flexible and semi-rigid. As will appear from the following description, such a semi-rigidity of the tubes allows maintaining the anchor pieces to which they are linked under slight tension, without having to apply any particular tension on these tubes. The flexible tubes may be in plastic material, silicone, or a combination of these materials.


In one embodiment of the invention, the mesh of the prosthesis of the invention is a knitted fabric: because of the stitches that form it, a knitted fabric makes it possible to obtain openwork faces encouraging cellular recolonization after implantation. The knitted fabric may be a two-dimensional knitted fabric or a three-dimensional knitted fabric.


In the context of the present application, the expression “two-dimensional knitted fabric” means a knitted fabric having two opposite faces linked together by stitches but having no spacers imparting a certain thickness to it: such a knitted fabric may be obtained, for example, by knitting threads on a warp or Raschel knitting machine using two guide bars. Examples of two-dimensional knitted fabrics suitable for the present invention are given in the document WO2009/071998.


In the present application, the expression “three-dimensional knitted fabric” means a knitted fabric having two opposite faces linked together by spacers imparting a significant thickness to the knitted fabric, said spacers consisting of connecting threads additional to the threads forming the two faces of the knitted fabric. Such a knitted fabric may be obtained, for example, using a double-bed Raschel knitting machine or warp knitting machine with a plurality of guide bars. Examples of knitting three-dimensional knitted fabrics suitable for the present invention are given in the documents WO99/05990, WO2009/031035, WO2009/071998.


In one embodiment, said frame is set back from the exterior peripheral edge of the mesh and is of serpentine shape, forming undulations. For example, said frame is in the form of a flat ribbon forming undulations substantially in the plane of said mesh. As will become apparent from the description given hereinafter, this configuration of the frame makes it possible, when fixing the prosthesis to the biological tissue, to execute a suture in the prosthesis at a given location without deforming the prosthesis as a whole during this operation; deformation of the prosthesis caused by the suture at the given location is smoothed out by the undulating frame. Thus the frame and therefore the rest of the prosthesis remain correctly positioned, and in particular remain pressed against the abdominal wall, during the fixing of the prosthesis.


In one embodiment, said reinforcing member is produced in bioresorbable material. Thus the reinforcing member fulfils its role of stiffening the prosthesis during positioning and implantation of the prosthesis and is then degraded progressively once the mesh is recolonized by the surrounding cells.


The bioresorbable material may be chosen, for example, from polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), oxidized cellulose, polyglycol acid (PGA), copolymers of these materials and mixtures thereof.


Alternatively, the reinforcing member is produced in a non-bioresorbable material chosen from polypropylene, a polyester such as polyethylene terephthalate, polyamide, silicone, polyetheretherketone (PEEK), polyaryletheretherketone (PAEK) and mixtures thereof.


In another embodiment, said reinforcing member is produced from a combination of bioresorbable material and non-bioresorbable material.


In one embodiment of the invention said mesh has the shape of a disc, said frame being substantially in the form of a circular ring. In such an embodiment, said anchor pieces may be fixed to two diametrically opposed places of an inner perimeter of said ring, said two places being spaced by 90° from each of said two hinge points. Such an embodiment enables an optimal deployment of the prosthesis by pulling in opposite directions on the respective thread-shaped elements of the two anchor pieces after the folded prosthesis has been introduced in the implantation site.


Alternatively, the prosthesis comprises four said anchor pieces distributed substantially regularly along an inner perimeter of said ring so that two anchor pieces are located on one side of the folding line and the other two anchor pieces are located on the other side of said folding line. In such an embodiment, for example, a single thread-shaped element links together the free parts of two anchor pieces located on the same side of the folding line. The total number of thread-shaped elements thus remains low and the surgeon is not impeded by the presence of extra thread-shaped elements. Moreover, the deployment and orientation step of the prosthesis is rendered easier: indeed, each thread-shaped element, because it links together the free parts of two anchor pieces located on the same side of the folding line, forms a sort of loop that the surgeon may very easily grasp and handle, in particular in view of exerting a tension on this loop: in addition, such a tension enables pulling on two anchor pieces simultaneously, at two different places of the mesh, thereby allowing optimised deployment and spreading out of the mesh and of the prosthesis.


Alternatively, a single thread-shaped element may link together the free parts of two adjacent anchor pieces located on each side of the folding line.


In embodiments, the anchor pieces have a colour different than that of the mesh. Alternatively or in addition, the thread-shaped elements have a colour different than that of the mesh and than that of the anchor pieces. Thanks to the present invention, the surgeon works in a relative non obstructed implantation site where he can see the area of the prosthesis to be attached to the abdominal wall, this area being located more or less in the middle between the centre of the mesh and the edge of the mesh: such embodiments of the prosthesis of the invention allow the surgeon to easily and rapidly make the necessary stitches by enabling him, thanks to the different colours, to quickly identify whether he handles the mesh, the anchor pieces or the thread-shaped elements.


In one embodiment of the invention, the face of the mesh opposite that including said anchor pieces is covered with a non-adherent coating.


Such a coating makes it possible in particular to avoid the formation of unwanted severe post-operative fibrous adhesions.


In the context of the present application the expression “non-adherent” refers to a non-porous, smooth, biocompatible coating or material offering no space for cellular recolonization and preferably encouraging the birth of a peritoneum.


In embodiments, where the prosthesis comprises four said anchor pieces distributed substantially regularly along an inner perimeter of said ring so that two anchor pieces are located on one side of the folding line and the other two anchor pieces are located on the other side of said folding line, all four anchor pieces are under the form of isosceles triangles of textile, each triangle being fixed to said mesh via its base, all four triangles showing identical elongation and tensile strength properties in the centripetal direction.


For example, each isosceles triangle is fixed to the mesh via its base by means of the ring, the thread-shaped element being attached to the vertex angle of the isosceles triangle. Because of the four isosceles triangles of textile having the same mechanical properties in the centripetal direction, when the surgeon pulls on the thread-shaped elements at the time he puts the prosthesis in place and fixes it to the abdominal wall, all anchor pieces react similarly and the traction exerted by the surgeon on the whole prosthesis via the thread-shaped elements is regularly distributed. The prosthesis is therefore properly positioned. In addition, in embodiments where the four isosceles triangles of textile have a colour different from that of the mesh, the surgeon readily identifies the stitching line as defined above and the step of fixing the prosthesis to the abdominal wall is facilitated. As will appear from the description below, the method of manufacturing a prosthesis with four anchor pieces under the form of four isosceles triangle of textile having identical mechanical properties is simple and easy.





The present invention will emerge more clearly from the description given hereinafter and from the appended drawings, in which:



FIG. 1 is a representation in section of a median abdominal hernia or ventral rupture,



FIG. 2 is a simplified view of the hernia from FIG. 1 after the surgeon has made an abdominal incision and removed the hernia sac,



FIG. 3 is a top view of one embodiment of a mesh for a prosthesis of the invention,



FIG. 4 is a top view of a reinforcing member for the prosthesis of the invention,



FIGS. 5A to 5D are views of anchor pieces of the prosthesis of the invention,



FIG. 6 is a top view of a first embodiment of the prosthesis of the invention,



FIG. 7 is a top view of another embodiment of the prosthesis of the invention,



FIG. 8 is a top view of another embodiment of the prosthesis of the invention,



FIG. 9 is a top view of another embodiment of the prosthesis of the invention,



FIG. 10 is a simplified sectional view of the introduction of the prosthesis from FIG. 8 into the hernia defect,



FIG. 11 is a simplified sectional view of the positioning of the prosthesis from FIG. 8 after deployment thereof at the implantation site,



FIG. 12 is a simplified sectional view of the fixing of the prosthesis from FIG. 8 to the abdominal wall,



FIG. 13 is a view in section of the prosthesis from FIG. 8 when fixed to the biological tissues just before closure of the abdominal incision by the surgeon,



FIG. 14-17 are top views showing the successive steps of the manufacturing process of a prosthesis of the invention comprising four anchor pieces of textile of identical mechanical properties.






FIG. 1 represents a hernia defect 100 of the abdominal wall 101 that is characterized by a break in the continuity of the aponeurosis 102 surrounding the straight muscles 103 and a passage through the peritoneum 104 forming a sac, the hernia sac 105, that contains either fat (epiploon) or part of the viscera 106, and which then presses on the fatty tissues 107 and is flush with the skin 108. One treatment of a hernia defect 100 entails replacing and retaining the viscera 106 in the abdominal cavity 109.



FIG. 2 shows the hernia defect 100 from FIG. 1 after the surgeon has made an incision in the skin 108, the abdominal wall 101 and the peritoneum 104 and has reduced the hernia sac. The viscera are not shown in FIG. 2: they have been pushed back into the abdominal cavity 109. The surgeon must now introduce into the abdominal cavity 109, via the incision 110 that has been made, a prosthesis for reinforcing the abdominal wall, before closing the incision 110 by means of sutures, for example. In the case of an umbilical hernia, the size of the incision 110 is particularly small, for example of the order of 1 to 4 cm diameter.



FIG. 3 represents a mesh 1 in the form of a disc usable with the reinforcing member from FIG. 4 and anchor pieces such as that from FIGS. 5A to 5D to produce a prosthesis of the invention.


The mesh 1 is made from a knitted, woven or non-woven arrangement of biocompatible threads. It may be bioresorbable, partly bioresorbable or permanent. The mesh is generally openwork, incorporating pores for better tissue integration. This mesh 1 is sufficiently flexible to be folded when the prosthesis is introduced into the abdominal cavity 109 via the incision 110. However, the mesh is generally a textile having no elasticity enabling it to return to a spread out configuration of its own accord after it has been folded up. The mesh 1 may be produced from a textile layer or a plurality of textile layers. The textile may be a two-dimensional or three-dimensional knitted fabric. Such meshes are well known to the person skilled in the art and are not described in more detail here. The mesh may be supplied in the form of a strip that is cut to the dimensions of the defect to be treated. In the example represented, the mesh 1 has the shape of a disc adapted to the shape of the incision 110 at the hernia defect 100 and delimited by an exterior peripheral edge 1a. In other embodiments, the mesh may be of oval shape. Alternatively, the mesh may be of rectangular or square shape.



FIG. 4 represents a reinforcing member of a prosthesis of the invention, suitable for the shape of the mesh 1 from FIG. 3: as is apparent from FIG. 4 and FIG. 6, the reinforcing member takes the form of a frame 2 substantially adopting the shape of the exterior peripheral edge 1a of the mesh 1. Thus the overall shape of the frame 2 is a circular ring. The frame 2 is provided with two hinge points 3a and 3b that are diametrically opposite in the example shown. The two hinge points (3a, 3b) make it possible to fold the frame 2, for example when force is applied by the surgeon, resulting in two globally identical parts. The hinge points (3a, 3b) preferably do not have any elasticity of their own: thus, once folded in two, the frame 2 can be unfolded only by the action of an external force, for example exerted by the surgeon.


The frame 2 thus consists of two parts, namely two semicircles 2a and 2b, connected together by two hinge points (3a, 3b). As seen in FIG. 4, the respective ends (2c; 2d) of the semicircles 2a and 2b are blunted or rounded to prevent trauma when implanting the prosthesis. In the example shown, the two semicircles 2a and 2b are symmetrical: the two hinge points (3a; 3b) define a median line M passing through the centre of the circle delimited by the frame and also through the centre of the mesh 1 when the frame 2 is fixed to the mesh 1, as shown in FIG. 6. Thus the mesh 1 may be folded in two even when fitted with the frame 2: consequently, as will become apparent in the remainder of the description, the prosthesis may be folded. Similarly, given the configuration of the frame 2 in two parts and the absence of any elasticity of the frame 2 and its hinge points (3a, 3b), the prosthesis is able to adopt only two configurations: either a flat and spread out configuration or a folded in two configuration. As explained later, the fact that the prosthesis can adopt only two configurations facilitates the task of the surgeon, who can immediately determine if the prosthesis is in its spread out configuration or not.


As seen in FIGS. 4 and 6, the frame 2 is an undulating ring set back from the exterior peripheral edge 1a, consisting of undulations 4. Referring to FIG. 6 in particular, the exterior peripheral edge 1a of the mesh extends some distance beyond the exterior contour of the frame 2: this distance may be greater than or equal to 1 mm, for example. As will become apparent from the description given hereinafter, the location of the frame 2, slightly set back from the exterior peripheral edge 1a, facilitates efficacious fixing of the prosthesis to the abdominal wall, in particular in an area located more or less half way between the centre and the edge of the mesh, this area being adjacent to the interior contour of the frame 2.


The undulations 4 of the frame 2 may be regular or not. In particular, in the example shown, the frame 2 is in the form of a flat ribbon of material forming undulations 4 in the plane of the frame 2, which is substantially the plane of the prosthesis. As will become apparent in the remainder of the description, such a shape imparts to the frame 2 great flexibility in the plane of the frame 2 and thus in the plane of the prosthesis: it is thus possible to suture part of the prosthesis at a given place, without rocking or deforming the prosthesis as a whole: the deformation created at the location of the suture is smoothed out by the undulations 4 of the frame 2 over the whole of the periphery of the prosthesis. In addition, the frame 2 shows a rigidity along its section, so that it neither deforms radially in the outward nor in the inward directions.


Materials suitable for producing the reinforcing member of the prosthesis of the invention may be any biocompatible materials having some rigidity so as to respond to the expectations disclosed above.


The frame 2 can thus be produced in any biocompatible material, bioresorbable or not. In a preferred embodiment, it is made in bioresorbable material. In the present application, the term “bioresorbable” refers to the characteristic whereby a material is absorbed by biological tissues and disappears in vivo after a given period, which may vary from one day to several months, for example, depending on the chemical nature of the material.


Bioresorbable materials suitable for the fabrication of the reinforcing member of the prosthesis of the present invention include polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), oxidized cellulose, polyglycolic acid (PGA), copolymers of these materials and mixtures thereof. Bioresorbable materials suitable for the fabrication of the reinforcing member of the prosthesis of the invention include polyester (glycolid, dioxanone, trimethylene carbonate) available from the company Covidien under the trade name “BIOSYN®” and polyester (glycolid, caprolactone, trimethylene carbonate, lactid) available commercially from the company Covidien under the trade name “CAPROSYN®”.


Non-bioresorbable materials suitable for the fabrication of the reinforcing member of the prosthesis of the present invention include polypropylene, polyesters such as polyethylene terephthalate, polyamide, silicone, polyetheretherketone (PEEK), polyaryletheretherketone (PAEK) and mixtures thereof.


Each part of the reinforcing member of the prosthesis of the invention may be made in one piece, for example, by injection moulding one or more biocompatible thermoplastic or thermosetting materials. The hinge points (3a, 3b) of the frame 2 may be produced in the same material as the rest of the frame: these hinge points (3a, 3b) take the form for example of very thin bridges of material in order to enable folding of the frame 2 without causing separation of the two parts joined together by these bridges.


With reference to FIGS. 5A to 5D are shown, on their own, examples of anchor pieces 5 suitable for the prosthesis of the invention, each provided with a thread-shaped element (6, 7). The anchor pieces may show any geometrical shape, for example triangular, squared, semicircular. They may be identical or different for a single prosthesis.


In embodiments, such as those shown on FIGS. 5A to 5 B, the anchor pieces 5 show a geometrical shape where at least one side has a length greater than or equal to that of the other sides. Thus, with reference to FIG. 5A, the anchor piece 5 has the shape of a triangle. In this example, the triangle is isosceles and the basis B of the triangle is the side having the greatest length. As will appear hereinafter, the longest side of the anchor piece 5 will form the fixed part 5a of the anchor piece 5 while the area located around the summit C opposed to that basis B will form the free part 5b of the anchor piece 5. In the same way, with reference to FIG. 5B, the anchor piece 5 having globally the shape of a semi-disc, the diameter D forms the side of greater length of the anchor piece and will therefore form the fixed part 5a of the anchor piece, while the rounded part forms the free part 5b of the anchor piece 5. With reference to FIG. 5C, the anchor piece has globally the shape of an isosceles triangle the basis of which is an arc of circle: this basis will form the fixed part 5a of the anchor piece, while the area located around the summit opposed to that arc of circle will form the free part 5b of the anchor piece 5.


On FIG. 5D is shown an anchor piece 5 of trapezoid shape, the parallel sides of which show an arc of circle shape: the longest arc of circle forms the fixed part 5a of the anchor piece, while the area located around the shortest arc of circle forms the free part 5b of the anchor piece.


On FIGS. 5A to 5B, the free part 5b of each anchor piece is linked to a thread-shaped element. In the context of the present application, by “thread-shaped element”, is meant a flexible and elongated element, the length of which is much more greater than its thickness and its width, the contour of the cross section of which is globally circular: examples of thread-shaped elements of the invention may be a thread on its own, composite or not, or several threads, for example arranged together to make a braid, a tube, and combinations thereof. In embodiments, the thread-shaped elements are selected from threads, tubes and combinations thereof.


As will be apparent from the following detailed description, the thread-shaped element is intended to allow the surgeon to pull on the anchor piece linked thereto in order to expand, orientate and position the prosthesis when said prosthesis is put in place: preferably, the surgeon will pull simultaneously on the thread-shaped elements of the at least two anchor pieces which are present in order to centre and counterbalance the prosthesis with respect to the defect to be treated.


With reference to FIG. 5A, the free part 5b of the anchor piece is linked to a thread 6 passing through said free part 5b. On the example shown, the thread 6 forms a loop. Alternatively, the thread 6 may be attached by one of its ends to the free part 5b of the anchor piece 5. With reference to FIG. 5B, the free part 5b of the anchor piece is also linked to a thread 6 passing through said free part 5b, said thread 6 forming a loop at the location of said free part 5b, the two strands of the loop being further brought together within a tube 7.


With reference to FIG. 5C, the free part 5b of the anchor piece 5 is linked to a tube 7: on the example shown, the two ends 7a and 7b of tube 7 are attached to the free part 5b and the tube 7 forms a loop. With reference to FIG. 5D, the free part 5b of the anchor piece 5 is linked to one end 7a of a tube 7.


The tube 7 is flexible and, because of its hollow structure, necessitating a certain outer diameter, for example equal to or greater than 3 mm, it shows a quite important outer surface capable of being in contact with the margins of the defect, this allowing decreasing dramatically the potential traumatic effect due to the contact of the tube 7 with the margins of the defect. The flexible tube 7 may be in plastic material, silicone, or in a combination of these materials.


The anchor pieces 5 of the prosthesis of the invention are made of a suturable material: in the context of the present application, it is hereby meant that the anchor piece 5 is capable of being linked to, or passed through by, a thread-shaped element, such as a thread 6 or a tube 7, without being torn off when a user, such as a surgeon for example, exerts a moderate tension on said thread-shaped element, such as the necessary tension for orientating and/or positioning the prosthesis in the implantation site, as described hereinafter. The anchor pieces 5 may be made of any biocompatible suturable material giving them the necessary flexibility for being grasped by the surgeon when the prosthesis is put in place, as will be described hereinafter.


The anchor piece 5 may be under the form of a textile, either knitted, woven or nonwoven, open worked or not; alternatively or in addition, the anchor piece may be under the form of a film or a sheet of material, as long as this textile, film and/or sheet of material is not torn off under the effect of the moderate tension as described above exerted on a thread-shaped element linked to, or passing through, said textile, film and/or sheet.


As will be apparent from the following description, the anchor pieces are useful to the surgeon for facilitating the positioning of the prosthesis in the centre of the defect to be treated, and for attaching the prosthesis to the biological tissues. The anchor pieces also form the parts of the prosthesis by which said prosthesis is sutured to the abdominal wall.


With reference to FIG. 6 is shown a prosthesis 200 according to the invention, comprising the mesh 1 of FIG. 3, the reinforcing member 2 of FIG. 4 and two anchor pieces 5 similar to the anchor piece of FIG. 5C, each anchor piece 5 being on that FIG. 6 linked to a thread-shaped element under the form of a thread 6.


As is apparent from this FIG. 6, the anchor pieces 5 are each attached to the mesh 1 by their longer side forming the fixed part 5a of the anchor piece: the fixing of each anchor piece 5 by its longer side allows a more reliable fixation. Moreover, the fixed part 5a of each anchor piece 5 is attached along the direction of the line P which is perpendicular to the segment S linking the centre of the mesh and the point of fixation of each piece in the plane of the mesh. The fixed part 5a or longer side of each anchor piece is fixed to the mesh for example by sewing. Alternatively, it may be fixed to the mesh 1 by gluing, welding or by means of the reinforcing member 2.


The anchor pieces 5 being fixed to the mesh by their longest side, they do not impede the surgeon at the time of the prosthesis is implanted. On FIG. 6, the two anchor pieces 5 are fixed to two diametrically opposed places of an inner perimeter of the ring 2, said two places being spaced by 90° from each of said two hinge points (3a, 3b).


With reference to FIGS. 7 to 9 are shown prosthesis 200 of the invention made with the mesh 1 from FIG. 3, the frame 2 from FIG. 4 and four anchor pieces 5 from FIG. 5A, linked to various thread-shaped elements.


In these embodiments, the four anchor pieces 5 are arranged regularly along an inner perimeter of the ring formed by the frame 2 so that two anchor pieces 5 are located on one side of the folding line M and the two other anchor pieces are located on the other side of the folding line M: the four anchor pieces therefore counterbalance one another. Each anchor piece 5 is fixed to the mesh 1 by its fixed part 5a, the free parts 5b being left flying and forming flaps. For example, each fixed part 5a is attached to the mesh 1 by a seaming 8. Moreover, a single thread-shaped element (6, 7) links together the free parts 5b of two anchor pieces 5 located on the same side of the folding line M.


With reference to FIG. 7, the thread-shaped element is under the form of a combination of a thread 6 and a tube 7: the thread 6 forms a loop at the place of the free part 5b of the anchor piece it is linked to, the two strands of the loop being brought together within a tube 7 at the place of grasping of the thread-shaped element by the surgeon. Such an embodiment allows an easier and more comfortable grasping of the thread-shaped element by the surgeon.


With reference to FIG. 8, the thread-shaped element is under the form of a tube 7: the first end 7a of the tube 7 is attached to the free part of a first anchor piece 5 while the second end 7b of the same tube 7 is attached to the free part 5b of the adjacent anchor piece located on the same side of the folding line M as the first anchor piece 5. Such an embodiment, in which the thread-shaped element is a tube 7, allows an easier and more comfortable grasping of the thread-shaped element, while limiting the risk of trauma when the thread-shaped element contacts the margins of the defect to be treated at the time of positioning the prosthesis 200. The tube 7 may itself contain one or several threads.


With reference to FIG. 9, the thread-shaped element is under the form of a thread 6 forming a loop at the place of the free part 5b of a first anchor piece 5 and at the place of the free part 5b of a adjacent anchor piece located on the same side of the folding line M as the first anchor piece 5.


The presence of the four anchor pieces 5, regularly distributed as described above in FIGS. 7 to 10, and of the thread-shaped elements linking anchor pieces 5 by pairs enables the surgeon to optimally spread out the prosthesis 200 on the implantation site and to balance the tension between the various anchor pieces 5 at the time of positioning the prosthesis 200 and to centre the latter prosthesis better relative to the defect to be closed.


In one embodiment of the prosthesis 200 not shown, the reinforcing member, namely the frame 2, is welded directly to the mesh 1 and to the fixed parts 5a of anchor pieces 5. Thus the frame 2 is fastened both to the mesh 1 and to the anchor pieces 5.


In the FIG. 8 embodiment, the face of the mesh 1 opposite that including the anchor pieces 5 is covered by a non-adherent coating 201. Such a non-adherent coating makes it possible to avoid in particular the formation of unwanted severe post-operative fibrous adhesions; once the prosthesis 200 has been implanted, the face of the prosthesis 200 covered by the non-adherent coating 201 faces the abdominal cavity 109.


The non-adherent coating or material is chosen from bioresorbable materials, non-bioresorbable materials and mixtures thereof. The non-bioresorbable non-adherent materials may be chosen from polytetrafluoroethylene, polyethylene glycol, polysiloxane, polyurethane, and mixtures thereof.


Said non-adherent coating or material is preferably bioresorbable: bioresorbable materials suitable for said non-adherent coating may be chosen from collagen, oxidized cellulose, polyacrylate, trimethylene carbonate, caprolactone, dioxanone, glycolic acid, lactic acid, glycolide, lactide, polysaccaride, for example chitosan, polyglucuronic acid, hyaluronic acid, dextran and mixtures thereof.


The non-adherent coating makes it possible to protect the mesh 1 of the prosthesis 200 at least during the initial scar formation phase, i.e. the mesh 1 is not exposed to inflammatory cells, such as granulocytes, monocytes, macrophages or the giant multinucleated cells generally activated by surgery. At least during the initial scar formation phase, the duration of which may vary from about 5 days to about 10 days, only the non-adherent coating is accessible to the various factors such as proteins, enzymes, cytokines or inflammatory cells.


If the non-adherent coating consists of non-resorbable materials, it thus protects the mesh 1 before and after implantation and throughout the duration of implantation of the prosthesis 200.


Moreover, thanks to the non-adherent coating, surrounding fragile tissues, such as the hollow viscera, for example, are protected, in particular from unwanted severe post-operative fibrous adhesion.


If the non-adherent material includes a bioresorbable material, it is preferable to choose a bioresorbable material that is not resorbed in less than a few days in order for the non-adherent coating to be able to fulfil its function of protecting the intestine and hollow organs during the days following surgery until cellular rehabilitation of the prosthesis takes over protecting these fragile organs.


Because of its two-part reinforcing member, namely the frame 2 consisting of the two semicircles 2a and 2b in the example shown, connected together by hinge points 3a, 3b, the prosthesis 200 of the invention may adopt a folded configuration after the surgeon folds it along the folding line M. Thus to implant the prosthesis 200 the surgeon folds it in two so that it occupies a smaller volume, which facilitates introduction of the prosthesis into the hernia defect 100 (see FIG. 2) by the surgeon.


The mesh 1 and the non-adherent coating 201 are sufficiently flexible to follow successive deformations of the prosthesis 200 as the latter is introduced to the implantation site.



FIGS. 14-17 describe various steps of a method for manufacturing an embodiment of a prosthesis 210 of the invention made with the mesh 1 of FIG. 3, the frame 2 of FIG. 4 and four anchor pieces 215. For clarity's sake, the thread-shaped elements are not shown on FIGS. 14-17: these thread-shaped elements may be any one of FIGS. 6-9 and may be attached to said anchor pieces 215 as described above.


As will appear from the description below, the four anchor pieces 215 of prosthesis 210 are arranged symmetrically along the interior contour of the ring formed by the frame 2, and they all have the same mechanical properties.


The manufacturing process of such embodiments will now be described with reference to FIGS. 14-17.


With reference to FIG. 14, is shown a textile 20 for forming the anchor pieces 215 of the prosthesis 210 (see FIG. 17). On the example shown, the textile 20 has the shape of a square, the length of one side of the square being greater than the greater diameter of the intended resulting prosthesis 210. This textile 20 may be identical to that forming the mesh 1 or different. The textile 20 is for example produced on a knitting machine and has a warp direction Wa and a weft direction We, as shown on this FIG. 14. The textile 20 may have different mechanical properties, such as elongation and tensile strength, along its warp direction Wa and along its weft direction We.


Preferably, the textile 20 has a colour different from that of the mesh 1.


In order to proceed with the manufacturing of the four anchor pieces 215, a cutting 21 having the shape of a cross with two perpendicular branches (22, 23) is completed on textile 20, with one branch 22 of the cross parallel to the warp direction Wa and the other branch 23 of the cross parallel to the weft direction We, as shown on FIG. 15. The branches of the cross may be of identical lengths or not. On the example shown on FIG. 15, the length of the branch 22 parallel to the warp direction Wa is smaller than the length of the branch 23 parallel to the weft direction. In addition, on this example and as will appear from FIG. 16, the length of the branch 22 parallel to the warp direction Wa is smaller than the diameter of the internal perimeter of the frame 2, whereas the length of the branch 23 parallel to the weft direction is greater than the diameter of the outer perimeter of the frame 2.


In a further step, the textile 20 is laid upon a piece of mesh 1, for example of similar square shape and dimensions as the textile 20, and the frame 2 of FIG. 4 is then welded to both the mesh 1 and the textile 20.


As shown on FIG. 16, the frame 2 is welded on mesh 1 and textile 20 so that the greater branch 23 of the cutting 21 is applied on the folding line M defined by the frame 2 (see FIG. 4) and extends beyond the hinge points (3a, 3b) of the frame 2, whereas the smaller branch 22 of the cutting 21 does not reach the frame 2. Such an embodiment allows a better efficiency of the frame 2, which may not be damaged by residual filaments coming from the cutting of branch 22 when said frame 2 is welded on both the mesh 1 and the textile 20.


Once the frame 2 is welded, the disc-shape prosthesis 210 may be manufactured by cutting the mesh 1 and textile 20 in excess beyond the outer peripheral border of the frame 2, as shown on FIG. 17. As appears from this Figure, the frame 2 forms together with the cross-shaped cutting 21 four isosceles triangles 24, more or less fixed to the frame 2 by their respective base 24a and free at their vertex angle 24b. These four isosceles triangles 24 of textile 20 form the anchor pieces 215 of the prosthesis 210.


As mentioned above, a thread-shaped element (not shown) may then be attached to the free vertex angle 24b of each triangle 24 by any fixation means such as those described above at FIGS. 6-9, in line with the direction defined by the altitude 24c drawn from the vertex angle 24b of each triangle 24.


Because of the specific cross-shaped cutting 21, with one branch parallel to the warp direction Wa and the other branch parallel to the weft direction We, all four isosceles triangles 24 of textile 20 are identical and they all show the same mechanical properties, such as elongation properties and tensile strength properties, each in the direction of its altitude 24c corresponding to the centripetal direction of the disc-shape prosthesis 210, regardless from the fact that the initial elongation and tensile strength properties of the textile 20 in its warp direction Wa were identical or not to its initial elongation and tensile strength properties in the weft direction We.


Indeed, because of the location of the cutting 21 with respect to the frame 2 during the welding step, the altitude direction or centripetal direction for each triangle 24 forms an angle of 45° with respect to both warp and weft directions of the initial textile 20.


As a consequence, all four anchor pieces 215 show the same mechanical properties, in particular elongation properties and tensile strength properties, in the direction corresponding to the direction of the altitude 24c of each triangle 24, in other words in the direction corresponding to the direction of the traction exerted by the surgeon when he pulls on the thread-shaped element (not shown) in order to put the prosthesis in place and to fix it to the abdominal wall.


As a consequence, when the surgeon pulls on the thread-shaped element at the time he puts the prosthesis 210 in place and fixes it to the abdominal wall, all anchor pieces 215 react similarly and the traction exerted by the surgeon on the whole prosthesis 210 via the four anchor pieces is equally distributed. The prosthesis 210 is therefore properly positioned. In addition, because the four isosceles triangles 24 of textile 20 have a colour different from that of the mesh 1, the surgeon readily identifies the stitching line as defined above. The step of fixing the prosthesis 210 to the abdominal wall is therefore facilitated.


The method of manufacturing the prosthesis 210 described above is very simple and allows starting from a single piece of textile 20 for manufacturing the four anchor pieces 215.


Alternatively, the prosthesis 210 may be manufactured by preparing initially four separate triangles 24 of textile 20 and welding each triangle 24 to the mesh 1 via the frame 2, or alternatively by preparing two pieces of semi-discs of textile 20, completing a perpendicular cutting on each semi-disc and welding the two cut semi-discs to the mesh via the frame 2.


Like the prosthesis 200 of FIGS. 1-13, the prosthesis 210 of FIG. 17 may be coated on the face of the mesh 1 opposite that including the anchor pieces 215 with a non-adherent coating 201.


The fitting of a prosthesis of the invention, for example the prosthesis 200 from FIG. 8, is described next with reference to FIGS. 10 to 13. Although not described, the fitting of the prosthesis 210 of FIG. 17 may be completed in the same manner as that described hereinafter for prosthesis 200 of FIG. 8.


After making the incision 110 described with reference to FIG. 2, the surgeon grasps the prosthesis 200 from FIG. 8, covered with a non-adherent coating 201 on the face of the mesh 1 opposite that including the anchor pieces 5, and applies force to the prosthesis 200 with his fingers to fold it along the folding line M. Because of the presence of the two hinge points 3a and 3b, this operation is without difficulty and totally independent of the elastic or non-elastic nature of the frame 2. In the embodiment shown, the prosthesis 200 being a disc, it is folded along one of its diameters, resulting in two identical parts. In this folded configuration, the prosthesis 200 occupies a small volume and the surgeon may easily introduce it into the abdominal cavity 109, as shown in FIG. 10, while holding the thread-shaped elements, in other words the tubes 7 in the example shown, outside the body of the patient. Because of their structure, the thread-shaped elements allow limiting the volume of the various elements which need to be passed through the hernia defect. For clarity, the fingers of the surgeon are not represented in FIGS. 10 to 13.


Once the prosthesis 200 is in the abdominal cavity 109, the surgeon releases the pressure on it. It is the surgeon who manually deploys the prosthesis 200 in a perfectly tensioned and spread out configuration. Thus, the prosthesis 200 being able to adopt only two positions, namely folded in two or spread out, the surgeon is certain that the prosthesis is perfectly spread out from the moment of unfolding the prosthesis 200.


In the next step, as shown in FIG. 11, the surgeon uses the thread-shaped elements, i.e. the tubes 7, both to centre the prosthesis 200 relative to the incision 110 and to press the prosthesis 200 against the abdominal wall (101, 104). To this end, the surgeon pulls the tubes 7 toward the exterior of the body of the patient and in opposite directions. The surface of the tubes 7 capable of being in contact with the margins of the defect being quite important, the risk of trauma is low. Moreover, the distribution of the anchor pieces 5 as explained above allows balancing and centring the prosthesis 200 on the defect to be treated while pressing said prosthesis on the abdominal wall. Thus the prosthesis 200 is spread perfectly and there is no risk of the viscera being disposed between the anchor pieces 5 and the abdominal wall (101, 104).


Once the prosthesis 200 is correctly positioned relative to the hernia defect, the surgeon raises a part of the edge of the hernia with the help of the tubes 7 and thus uncovers a central area 12 in the vicinity of the prosthesis 200, delimited overall by the anchor pieces 5, which area the surgeon may easily view and in which the surgeon is able to work easily.


In an embodiment, the tubes 7 are flexible and semi-rigid. Such a semi-rigidity of the tubes 7 allows maintaining the anchor pieces 5 to which they are linked under slight tension, without having to apply any particular tension on these tubes: as such, once the surgeon has raised the edges of the hernia defect by pulling on the flexible and semi-rigid tubes 7 in order to uncover a working area, he can release the tension on the tubes 7: the anchor pieces 5 remain under slight tension and maintain the edges of the defect in a raised position.


In embodiments, the anchor pieces 5 are of a colour different than that of the mesh 1: indeed, because the fixation area of the prosthesis 200 to the abdominal wall (101, 104) is located more or less in the middle between the centre 1b of the mesh 1 and the edge of the mesh, the surgeon can differentiate the different colours between the various elements forming the prosthesis 200 and thus easily identify the anchor pieces 5 he has to suture: such a thing is not possible with the prosthesis of the prior art intended to be fixed to the abdominal wall at their periphery. In particular, the colour difference between the anchor pieces 5 and the mesh 1 defines a line, said line pointing out to the surgeon where to complete the stitches for fixing the prosthesis 200 to the abdominal wall. This fixing line, or stitching line, globally corresponds to the interior contour of the frame 2. Also, for the same reasons, the thread-shaped elements, like the tubes 7, may be of a colour different from that of the mesh and from that of the anchor pieces 5.


In a following step, as shown in FIG. 12, the surgeon proceeds to fix the prosthesis 200 to the biological tissues by using a needle 9 and a suture 10 to suture the free part 5b of each anchor piece 5 to the abdominal wall 101, 104 within the central working area 12. During this step, the whole of the prosthesis 200 remains perfectly spread out and perfectly pressed onto the abdominal wall 104, notably by virtue of the presence of the undulations 4 of the frame 2, which smooth out deformations caused by the surgeon in the area of the prosthesis 200 that is in the process of being sutured. The surgeon may execute one or more stitches 11 (see FIG. 13) for each free part 5b of the four anchor pieces 5.


As may be seen in FIG. 13, the structure of the prosthesis 200 of the invention enables the surgeon to place the stitches 11 in an area situated more or less in the middle between the centre of the mesh 1 and the exterior peripheral edge 1a thereof; thus the surgeon does not have to execute stitches at the exterior peripheral edge 1a of the mesh 1, which can be viewed only with difficulty because of the small size of the incision 110. The mesh 1 nevertheless remains perfectly pressed against the abdominal wall 104 along this peripheral edge 1a because of the presence of the frame 2. Nevertheless, because of the structure of the prosthesis 200 of the invention, the stitches 11 are advantageously situated at some distance from the defect, in particular in an area more or less in the middle between the centre 1b of the mesh (which is the location of the hernia defect) and the edge 1a of the mesh, at a location where the biological tissues are often healthier and less fragile than at the margin of the defect. The stitches 11 may for example be U-shaped, i.e. obtained with a thread provided with a needle at each of its ends.


Once the surgeon has executed the necessary stitches 11 over all the anchor pieces 5, he cuts each thread-shaped element, here each tube 7, at its junction with the free part 5b of the anchor piece 5 in order to retain at the implantation site only the anchor pieces 5, as shown in FIG. 13. This figure shows the stitches 11 that fix the free parts 5b of the anchor pieces 5 to the abdominal wall 104. As may be seen in FIG. 13, the prosthesis 200 is thus perfectly deployed, spread out and pressed against the abdominal wall (101, 104) with no risk of trapping viscera between the prosthesis 200 and the abdominal wall (101, 104).


The surgeon then has only to close the incision 110 in the conventional way for small size hernias, i.e. by stitches.


The prosthesis of the invention is particularly simple to install, the surgeon being easily able to uncover a comfortable and non obstructed working area, despite the restricted size of the implantation site. The fitting of the prosthesis of the invention is also particularly reliable, all risk of trapping the viscera being avoided. A prosthesis of the invention is particularly suitable for treating umbilical hernias where the abdominal incision made is of small size. The prosthesis of the invention is adapted to adopt a configuration in which it occupies a particularly small volume facilitating its introduction into the abdominal cavity via a small incision without necessitating the use of any dedicated ancillary device. Thanks to its particular structure, the prosthesis of the invention may be spread out and pressed onto the abdominal wall efficaciously, also without necessitating the use of a dedicated tool to assist spreading it and it may be attached securely to the abdominal wall at an area located more or less in the middle between the centre of the prosthesis and its periphery: the surgeon is therefore prevented from having to make stitches at far distance places, such as the periphery of the prosthesis, that he cannot see. The prosthesis of the invention thus makes it possible to treat a hernia, in particular an umbilical hernia, efficaciously, simply and rapidly, minimizing the risk of relapse.

Claims
  • 1. A prosthesis comprising: at least one flexible mesh defined by a peripheral exterior edge,at least one reinforcing frame secured to the mesh and substantially adopting a shape of the peripheral exterior edge of the mesh, the frame being set back from the peripheral exterior edge and defining an inner perimeter, the frame being provided with two hinge points, a folding line passing through the two hinge points also passing through a center of the mesh for folding the mesh in twoat least two anchor pieces located on a first face of the mesh on either side of the folding line, each anchor piece including a fixed part linked to the mesh and a free part linked to at least one thread-shaped element, wherein at least one anchor piece has a shape selected from the group consisting of a semi-disc a base of which represents a diameter of the disc, an isosceles triangle a base of which is an arc of a circle, or a trapezoidal shape.
  • 2. A prosthesis according to claim 1, wherein each anchor piece is linked to the mesh by its longest side, along a direction perpendicular to a segment linking the center of the mesh and a point of fixation of the piece in a plane of the mesh.
  • 3. A prosthesis according to claim 1, wherein the at least one thread-shaped elements are selected from threads, flexible tubes and combinations thereof.
  • 4. A prosthesis according to claim 3, wherein the thread-shaped elements are flexible tubes.
  • 5. A prosthesis according to claim 4, wherein the flexible tubes are semi-rigid.
  • 6. A prosthesis according to claim 1, wherein the frame set back from the peripheral external edge is of serpentine shape forming undulations.
  • 7. A prosthesis according to claim 6, wherein the frame takes the form of a flat ribbon forming undulations substantially in a plane of the mesh.
  • 8. A prosthesis according to claim 1, wherein the reinforcing frame is produced in bioresorbable material.
  • 9. A prosthesis according to claim 1, wherein the mesh is disc-shaped, the reinforcing frame being substantially in a form of a circular ring.
  • 10. A prosthesis according to claim 9, wherein the at least two anchor pieces are fixed to diametrically opposed places of an inner perimeter of the ring, the two places being spaced by 90° from each of the two hinge points.
  • 11. A prosthesis according to claim 9, wherein the prosthesis comprises four anchor pieces distributed substantially regularly along an inner perimeter of the ring so that two anchor pieces are located on one side of the folding line and the other two anchor pieces are located on the other side of the folding line.
  • 12. A prosthesis according to claim 11, wherein a single thread-shaped element links together the free parts of two anchor pieces located on the same side of the folding line.
  • 13. A prosthesis according to claim 11, wherein all four anchor pieces are under the form of isosceles triangles of textile, all four triangles showing identical elongation and tensile strength properties in a centripetal direction.
  • 14. A prosthesis according to claim 1, wherein the anchor pieces have a color different than that of the mesh.
  • 15. A prosthesis according to claim 1, wherein the thread-shaped elements have a color different than that of the mesh and than that of the anchor pieces.
  • 16. A prosthesis according to claim 1, wherein the face of the mesh opposite that including the anchor pieces is covered by a non-adherent coating.
  • 17. A prosthesis according to claim 1, wherein the at least two anchor pieces are separate individual pieces.
  • 18. A prosthesis according to claim 1, wherein the at least one thread-shaped element comprises at least one thread linked to the free part of the at least two anchor pieces, wherein the at least one thread passes through at least one flexible tube between the free part of the at least two anchor pieces.
  • 19. A prosthesis according to claim 1, wherein the frame is rigid and the hinge points do not have any elasticity.
  • 20. A prosthesis according to claim 19, wherein the prosthesis is configured to adopt only two configurations including a flat and spread out first configuration and a fold evenly in two configuration.
Priority Claims (1)
Number Date Country Kind
11/56425 Jul 2011 FR national
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional application of U.S. patent application Ser. No. 16/927,735 filed Jul. 13, 2020, which is a continuation of U.S. patent application Ser. No. 15/963,523 filed Apr. 26, 2018, now U.S. Pat. No. 10,709,538, which is a continuation application of U.S. patent application Ser. No. 14/232,378 filed Mar. 24, 2014, now U.S. Pat. No. 9,980,802, which is a National Stage Application of PCT/EP2012062672 filed Jun. 29, 2012, which claims benefit of and priority to French Patent Application No. 11/56425 filed Jul. 13, 2011, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.

US Referenced Citations (475)
Number Name Date Kind
1187158 Mcginley Jun 1916 A
2153889 Hames Apr 1939 A
3054406 Usher Sep 1962 A
3118294 Van Laethem Jan 1964 A
3124136 Usher Mar 1964 A
3272204 Artandi et al. Sep 1966 A
3276448 Kronenthal Oct 1966 A
3320649 Naimer May 1967 A
3364200 Ashton et al. Jan 1968 A
3570482 Shigeru et al. Mar 1971 A
3718725 Hamano Feb 1973 A
4006747 Kronenthal et al. Feb 1977 A
4060081 Yannas et al. Nov 1977 A
4173131 Melton et al. Nov 1979 A
4193137 Heck Mar 1980 A
4248064 Odham Feb 1981 A
4294241 Miyata Oct 1981 A
4307717 Hymes et al. Dec 1981 A
4338800 Matsuda Jul 1982 A
4476697 Schafer et al. Oct 1984 A
4487865 Balazs et al. Dec 1984 A
4500676 Balazs et al. Feb 1985 A
4511653 Play et al. Apr 1985 A
4527404 Nakagaki et al. Jul 1985 A
4591501 Cioca May 1986 A
4597762 Walter et al. Jul 1986 A
4603695 Ikada et al. Aug 1986 A
4631932 Sommers Dec 1986 A
4670014 Huc et al. Jun 1987 A
4709562 Matsuda Dec 1987 A
4748078 Doi et al. May 1988 A
4759354 Quarfoot Jul 1988 A
4769038 Bendavid et al. Sep 1988 A
4796603 Dahlke et al. Jan 1989 A
4813942 Alvarez Mar 1989 A
4841962 Berg et al. Jun 1989 A
4854316 Davis Aug 1989 A
4925294 Geshwind et al. May 1990 A
4931546 Tardy et al. Jun 1990 A
4942875 Hlavacek et al. Jul 1990 A
4948540 Nigam Aug 1990 A
4950483 Ksander et al. Aug 1990 A
4970298 Silver et al. Nov 1990 A
4976737 Leake Dec 1990 A
5002551 Linsky et al. Mar 1991 A
5015584 Brysk May 1991 A
5116357 Eberbach May 1992 A
5147374 Fernandez Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5171273 Silver et al. Dec 1992 A
5176692 Wilk et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5195542 Gazielly et al. Mar 1993 A
5196185 Silver et al. Mar 1993 A
5201745 Tayot et al. Apr 1993 A
5201764 Kelman et al. Apr 1993 A
5206028 Li Apr 1993 A
5217493 Raad et al. Jun 1993 A
5254133 Seid Oct 1993 A
5256418 Kemp et al. Oct 1993 A
5258000 Gianturco Nov 1993 A
5263983 Yoshizato et al. Nov 1993 A
5304595 Rhee et al. Apr 1994 A
5306500 Rhee et al. Apr 1994 A
5324775 Rhee et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334527 Brysk Aug 1994 A
5339657 Mcmurray Aug 1994 A
5350583 Yoshizato et al. Sep 1994 A
5356432 Rutkow et al. Oct 1994 A
5368549 Mcvicker Nov 1994 A
5368602 Torre Nov 1994 A
5370650 Jonathan et al. Dec 1994 A
5376375 Rhee et al. Dec 1994 A
5376376 Li Dec 1994 A
5397331 Himpens et al. Mar 1995 A
5399361 Song et al. Mar 1995 A
5413791 Rhee et al. May 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5428022 Palefsky et al. Jun 1995 A
5433996 Kranzler et al. Jul 1995 A
5441491 Verschoor et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5456693 Conston et al. Oct 1995 A
5456711 Hudson Oct 1995 A
5466462 Rosenthal et al. Nov 1995 A
5480644 Freed Jan 1996 A
5487895 Dapper et al. Jan 1996 A
5490984 Freed Feb 1996 A
5512291 Li Apr 1996 A
5512301 Song et al. Apr 1996 A
5514181 Light et al. May 1996 A
5522840 Krajicek Jun 1996 A
5523348 Rhee et al. Jun 1996 A
5536656 Kemp et al. Jul 1996 A
5543441 Rhee et al. Aug 1996 A
5565210 Rosenthal et al. Oct 1996 A
5567806 Abdul-Malak et al. Oct 1996 A
5569273 Titone et al. Oct 1996 A
RE35399 Eisenberg Dec 1996 E
5593441 Lichtenstein et al. Jan 1997 A
5595621 Light et al. Jan 1997 A
5601571 Moss Feb 1997 A
5607474 Athanasiou et al. Mar 1997 A
5607590 Shimizu Mar 1997 A
5614587 Rhee et al. Mar 1997 A
5618551 Tardy et al. Apr 1997 A
5634931 Kugel Jun 1997 A
5639796 Lee Jun 1997 A
5665391 Lea Sep 1997 A
5667839 Berg Sep 1997 A
5676967 Williams et al. Oct 1997 A
5681568 Goldin et al. Oct 1997 A
5686090 Schilder et al. Nov 1997 A
5686115 Vournakis et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5695525 Mulhauser et al. Dec 1997 A
5697978 Sgro Dec 1997 A
5700476 Rosenthal et al. Dec 1997 A
5700477 Rosenthal et al. Dec 1997 A
5702416 Kieturakis et al. Dec 1997 A
5709934 Bell et al. Jan 1998 A
5711960 Shikinami Jan 1998 A
5716409 Debbas Feb 1998 A
5720981 Eisinger Feb 1998 A
5732572 Litton Mar 1998 A
5743917 Saxon Apr 1998 A
5749895 Sawyer et al. May 1998 A
5752974 Rhee et al. May 1998 A
5766246 Mulhauser et al. Jun 1998 A
5766631 Arnold Jun 1998 A
5769864 Kugel Jun 1998 A
5771716 Schlussel Jun 1998 A
5785983 Furlan et al. Jul 1998 A
5800541 Rhee et al. Sep 1998 A
5814328 Gunasekaran Sep 1998 A
5833705 Ken et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5861034 Taira et al. Jan 1999 A
5863984 Doillon et al. Jan 1999 A
5869080 Mcgregor et al. Feb 1999 A
5871767 Dionne et al. Feb 1999 A
5876444 Lai Mar 1999 A
5891558 Bell et al. Apr 1999 A
5899909 Claren et al. May 1999 A
5906937 Sugiyama et al. May 1999 A
5910149 Kuzmak Jun 1999 A
5911731 Pham et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5919233 Knopf et al. Jul 1999 A
5922026 Chin Jul 1999 A
5931165 Reich et al. Aug 1999 A
5942278 Hagedorn et al. Aug 1999 A
5962136 Dewez et al. Oct 1999 A
5972022 Huxel Oct 1999 A
RE36370 Li Nov 1999 E
5993844 Abraham et al. Nov 1999 A
5994325 Roufa et al. Nov 1999 A
5997895 Narotam et al. Dec 1999 A
6001895 Harvey et al. Dec 1999 A
6008292 Lee et al. Dec 1999 A
6015844 Harvey et al. Jan 2000 A
6039686 Robert Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6043089 Sugiyama et al. Mar 2000 A
6051425 Morota et al. Apr 2000 A
6056688 Benderev et al. May 2000 A
6056970 Greenawalt et al. May 2000 A
6057148 Sugiyama et al. May 2000 A
6063396 Kelleher May 2000 A
6066776 Goodwin et al. May 2000 A
6066777 Benchetrit May 2000 A
6071292 Makower et al. Jun 2000 A
6077281 Das Jun 2000 A
6080194 Pachence et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6090116 D Aversa et al. Jul 2000 A
6113623 Sgro Sep 2000 A
6120539 Eldridge et al. Sep 2000 A
6132765 Dicosmo et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6153292 Bell et al. Nov 2000 A
6162962 Hinsch et al. Dec 2000 A
6165488 Tardy et al. Dec 2000 A
6171318 Kugel et al. Jan 2001 B1
6174320 Kugel et al. Jan 2001 B1
6176863 Kugel et al. Jan 2001 B1
6179872 Bell et al. Jan 2001 B1
6180848 Flament et al. Jan 2001 B1
6197325 Macphee et al. Mar 2001 B1
6197934 Devore et al. Mar 2001 B1
6197935 Doillon et al. Mar 2001 B1
6210439 Firmin et al. Apr 2001 B1
6214020 Mulhauser et al. Apr 2001 B1
6221109 Geistlich et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6258124 Darois et al. Jul 2001 B1
6262332 Ketharanathan Jul 2001 B1
6264702 Ory et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6270530 Eldridge et al. Aug 2001 B1
6277397 Shimizu Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6287316 Agarwal et al. Sep 2001 B1
6290708 Kugel et al. Sep 2001 B1
6306079 Trabucco Oct 2001 B1
6306424 Vyakamam et al. Oct 2001 B1
6312474 Francis et al. Nov 2001 B1
6319264 Tormala et al. Nov 2001 B1
6328686 Robert Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6371975 Cruise et al. Apr 2002 B2
6383201 Dong May 2002 B1
6391060 Ory et al. May 2002 B1
6391333 Li et al. May 2002 B1
6391939 Tayot et al. May 2002 B2
6408656 Ory et al. Jun 2002 B1
6410044 Chudzik et al. Jun 2002 B1
6413742 Olsen et al. Jul 2002 B1
6425924 Rousseau Jul 2002 B1
6428978 Olsen et al. Aug 2002 B1
6436030 Rehil Aug 2002 B2
6440167 Shimizu Aug 2002 B2
6443964 Ory et al. Sep 2002 B1
6447551 Goldmann Sep 2002 B1
6447802 Sessions et al. Sep 2002 B2
6448378 Devore et al. Sep 2002 B2
6451032 Ory et al. Sep 2002 B1
6451301 Sessions et al. Sep 2002 B1
6454787 Maddalo et al. Sep 2002 B1
6458889 Trollsas et al. Oct 2002 B1
6477865 Matsumoto Nov 2002 B1
6479072 Morgan et al. Nov 2002 B1
6485503 Jacobs et al. Nov 2002 B2
6500464 Ceres et al. Dec 2002 B2
6500777 Wiseman et al. Dec 2002 B1
6509031 Miller et al. Jan 2003 B1
6511958 Atkinson et al. Jan 2003 B1
6514286 Leatherbury et al. Feb 2003 B1
6514514 Atkinson et al. Feb 2003 B1
6540773 Dong Apr 2003 B2
6541023 Andre et al. Apr 2003 B1
6548077 Gunasekaran Apr 2003 B1
6554855 Dong Apr 2003 B1
6559119 Burgess et al. May 2003 B1
6566345 Miller et al. May 2003 B2
6575988 Rousseau Jun 2003 B2
6576019 Atala Jun 2003 B1
6596002 Therin et al. Jul 2003 B2
6596304 Bayon et al. Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
6599524 Li et al. Jul 2003 B2
6599690 Abraham et al. Jul 2003 B1
6610006 Amid et al. Aug 2003 B1
6613348 Jain Sep 2003 B1
6616685 Rousseau Sep 2003 B2
6623963 Mueller et al. Sep 2003 B1
6630414 Matsumoto Oct 2003 B1
6637437 Hungerford et al. Oct 2003 B1
6638284 Rousseau et al. Oct 2003 B1
6645226 Jacobs et al. Nov 2003 B1
6652594 Francis et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
6653450 Berg et al. Nov 2003 B1
6656206 Corcoran et al. Dec 2003 B2
6660280 Allard et al. Dec 2003 B1
6669735 Pelissier Dec 2003 B1
6670018 Fujita et al. Dec 2003 B2
6682760 Noff et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6706684 Bayon et al. Mar 2004 B1
6706690 Reich et al. Mar 2004 B2
6712859 Rousseau et al. Mar 2004 B2
6719795 Bryan et al. Apr 2004 B1
6723335 Moehlenbruck et al. Apr 2004 B1
6726660 Hessel et al. Apr 2004 B2
6730299 Tayot et al. May 2004 B1
6736823 Darois et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6737371 Planck et al. May 2004 B1
6743435 Devore et al. Jun 2004 B2
6746458 Cloud Jun 2004 B1
6752834 Geistlich et al. Jun 2004 B2
6755868 Rousseau Jun 2004 B2
6773723 Spiro et al. Aug 2004 B1
6783554 Amara et al. Aug 2004 B2
6790213 Cherok et al. Sep 2004 B2
6790454 Abdul et al. Sep 2004 B1
6800082 Rousseau Oct 2004 B2
6833408 Sehl et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6852330 Bowman et al. Feb 2005 B2
6869938 Schwartz et al. Mar 2005 B1
6872227 Sump et al. Mar 2005 B2
6893653 Abraham et al. May 2005 B2
6896904 Spiro et al. May 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6936276 Spiro et al. Aug 2005 B2
6939562 Spiro et al. Sep 2005 B2
6949625 Tayot Sep 2005 B2
6966918 Schuldt-Hempe et al. Nov 2005 B1
6971252 Therin et al. Dec 2005 B2
6974679 Andre et al. Dec 2005 B2
6974862 Ringeisen et al. Dec 2005 B2
6977231 Matsuda Dec 2005 B1
6984392 Bechert et al. Jan 2006 B2
6988386 Okawa et al. Jan 2006 B1
7011688 Gryska et al. Mar 2006 B2
7021086 Ory et al. Apr 2006 B2
7022358 Eckmayer et al. Apr 2006 B2
7025063 Snitkin et al. Apr 2006 B2
7041868 Greene et al. May 2006 B2
7060103 Carr et al. Jun 2006 B2
RE39172 Bayon et al. Jul 2006 E
7070558 Gellman et al. Jul 2006 B2
7087065 Ulmsten et al. Aug 2006 B2
7094261 Zotti et al. Aug 2006 B2
7098315 Schaufler Aug 2006 B2
7101381 Ford et al. Sep 2006 B2
7115220 Dubson et al. Oct 2006 B2
7156804 Nicolo Jan 2007 B2
7156858 Schuldt-Hempe et al. Jan 2007 B2
7175852 Simmoteit et al. Feb 2007 B2
7192604 Brown et al. Mar 2007 B2
7207962 Anand et al. Apr 2007 B2
7214765 Ringeisen et al. May 2007 B2
7226611 Yura et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7252837 Guo et al. Aug 2007 B2
7279177 Looney et al. Oct 2007 B2
7331199 Ory et al. Feb 2008 B2
7393319 Merade et al. Jul 2008 B2
7556598 Rao Jul 2009 B2
7594921 Browning Sep 2009 B2
7614258 Cherok et al. Nov 2009 B2
7615065 Priewe et al. Nov 2009 B2
7662169 Wittmann Feb 2010 B2
7670380 Cauthen, III et al. Mar 2010 B2
7682381 Rakos et al. Mar 2010 B2
7709017 Tayot et al. May 2010 B2
7718556 Matsuda et al. May 2010 B2
7732354 Fricke et al. Jun 2010 B2
7785334 Ford et al. Aug 2010 B2
7789888 Bartee et al. Sep 2010 B2
7799767 Lamberti et al. Sep 2010 B2
7806905 Ford et al. Oct 2010 B2
7824420 Eldridge et al. Nov 2010 B2
7828854 Rousseau et al. Nov 2010 B2
7900484 Cherok et al. Mar 2011 B2
7931695 Ringeisen Apr 2011 B2
8048441 Craig et al. Nov 2011 B2
8052759 Dupic et al. Nov 2011 B2
8079023 Chen Dec 2011 B2
8100924 Browning Jan 2012 B2
8123817 Intoccia et al. Feb 2012 B2
8142515 Therin et al. Mar 2012 B2
8157821 Browning Apr 2012 B2
8157822 Browning Apr 2012 B2
8182545 Cherok et al. May 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8206632 Rousseau et al. Jun 2012 B2
8215310 Browning Jul 2012 B2
8317872 Adams Nov 2012 B2
8323675 Greenawalt Dec 2012 B2
8343232 Adzich et al. Jan 2013 B2
8366787 Brown et al. Feb 2013 B2
8435307 Paul May 2013 B2
8470355 Skalla et al. Jun 2013 B2
8562633 Cully et al. Oct 2013 B2
8574627 Martakos et al. Nov 2013 B2
8709094 Stad et al. Apr 2014 B2
8734471 Deitch May 2014 B2
8753360 Gleiman et al. Jun 2014 B2
8758800 Stopek et al. Jun 2014 B2
8784294 Goddard Jul 2014 B2
8814887 Walther et al. Aug 2014 B2
8828092 Toso et al. Sep 2014 B2
8834864 Odar et al. Sep 2014 B2
8846060 Archibald et al. Sep 2014 B2
8865215 Ladet et al. Oct 2014 B2
8877233 Obermiller et al. Nov 2014 B2
8911504 Mathisen et al. Dec 2014 B2
8920370 Sholev et al. Dec 2014 B2
8945663 Pacetti Feb 2015 B2
8956373 Ford et al. Feb 2015 B2
8962006 Bayon et al. Feb 2015 B2
8968762 Ladet et al. Mar 2015 B2
8979935 Lozier et al. Mar 2015 B2
9034357 Stopek May 2015 B2
9113993 Lee Aug 2015 B2
9211175 Stopek et al. Dec 2015 B2
9216075 Bailly et al. Dec 2015 B2
9980802 Bailly et al. May 2018 B2
20020077661 Saadat Jun 2002 A1
20020087174 Capello Jul 2002 A1
20020095218 Carr et al. Jul 2002 A1
20030086975 Ringeisen May 2003 A1
20030114937 Leatherbury et al. Jun 2003 A1
20030133967 Ruszczak et al. Jul 2003 A1
20030225355 Butler Dec 2003 A1
20040019360 Farnsworth et al. Jan 2004 A1
20040034373 Schuldt-Hempe et al. Feb 2004 A1
20040054376 Ory et al. Mar 2004 A1
20040059356 Gingras Mar 2004 A1
20040101546 Gorman et al. May 2004 A1
20050002893 Goldmann Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050085924 Darois et al. Apr 2005 A1
20050113849 Popadiuk et al. May 2005 A1
20050137512 Campbell et al. Jun 2005 A1
20050142161 Freeman et al. Jun 2005 A1
20050148963 Brennan Jul 2005 A1
20050175659 Macomber et al. Aug 2005 A1
20050232979 Shoshan Oct 2005 A1
20050267521 Forsberg Dec 2005 A1
20050288691 Leiboff Dec 2005 A1
20060064175 Pelissier et al. Mar 2006 A1
20060116696 Odermatt et al. Jun 2006 A1
20060135921 Wiercinski et al. Jun 2006 A1
20060147501 Hillas et al. Jul 2006 A1
20060195010 Arnal et al. Aug 2006 A1
20060216320 Kitazono et al. Sep 2006 A1
20060252981 Matsuda et al. Nov 2006 A1
20060253203 Alvarado Nov 2006 A1
20060282103 Fricke et al. Dec 2006 A1
20070088391 Mcalexander et al. Apr 2007 A1
20070129736 Solecki Jun 2007 A1
20070198040 Buevich et al. Aug 2007 A1
20070299538 Roeber Dec 2007 A1
20080091276 Deusch et al. Apr 2008 A1
20080109017 Herweck et al. May 2008 A1
20080113001 Herweck et al. May 2008 A1
20080147099 Uen Jun 2008 A1
20080147200 Rousseau et al. Jun 2008 A1
20080172071 Barker Jul 2008 A1
20080255593 St-Germain Oct 2008 A1
20090035341 Wagener et al. Feb 2009 A1
20090036996 Roeber Feb 2009 A1
20090068250 Gravagna et al. Mar 2009 A1
20090105526 Piroli et al. Apr 2009 A1
20090163936 Yang et al. Jun 2009 A1
20090187197 Roeber et al. Jul 2009 A1
20090192530 Adzich et al. Jul 2009 A1
20090204129 Fronio Aug 2009 A1
20090216338 Gingras et al. Aug 2009 A1
20090270999 Brown Oct 2009 A1
20090281558 Li et al. Nov 2009 A1
20090318752 Evans et al. Dec 2009 A1
20100104608 Abuzaina et al. Apr 2010 A1
20100241145 Cook Sep 2010 A1
20100318108 Datta et al. Dec 2010 A1
20110015760 Kullas Jan 2011 A1
20110144667 Horton et al. Jun 2011 A1
20110178538 Cook Jul 2011 A1
20110190795 Hotter et al. Aug 2011 A1
20110236460 Stopek et al. Sep 2011 A1
20110238094 Thomas et al. Sep 2011 A1
20110251699 Ladet et al. Oct 2011 A1
20110257666 Ladet et al. Oct 2011 A1
20110266778 Jakobsson Nov 2011 A1
20120016388 Houard et al. Jan 2012 A1
20120029537 Mortarino Feb 2012 A1
20120065727 Reneker et al. Mar 2012 A1
20120082712 Stopek et al. Apr 2012 A1
20120116425 Intoccia et al. May 2012 A1
20120150204 Mortarino et al. Jun 2012 A1
20120165937 Montanari et al. Jun 2012 A1
20120179175 Hammell et al. Jul 2012 A1
20120179176 Wilson et al. Jul 2012 A1
20120197415 Montanari et al. Aug 2012 A1
20140044861 Boey et al. Feb 2014 A1
20140364684 Lecuivre et al. Dec 2014 A1
Foreign Referenced Citations (140)
Number Date Country
1317836 May 1993 CA
101489502 Jul 2009 CN
201879864 Jun 2011 CN
19544162 Apr 1997 DE
19718903 Dec 1997 DE
19636961 Mar 1998 DE
19751733 Dec 1998 DE
19832634 Jan 2000 DE
10019604 Oct 2001 DE
10120942 Oct 2001 DE
10043396 Jun 2002 DE
0194192 Sep 1986 EP
0248544 Dec 1987 EP
0263360 Apr 1988 EP
0276890 Aug 1988 EP
0372969 Jun 1990 EP
0531742 Mar 1993 EP
0544485 Jun 1993 EP
0552576 Jul 1993 EP
0611561 Aug 1994 EP
0614650 Sep 1994 EP
0621014 Oct 1994 EP
0625891 Nov 1994 EP
0637452 Feb 1995 EP
0664132 Jul 1995 EP
0705878 Apr 1996 EP
0719527 Jul 1996 EP
0774240 May 1997 EP
0797962 Oct 1997 EP
0800791 Oct 1997 EP
0827724 Mar 1998 EP
0836838 Apr 1998 EP
0847727 Jun 1998 EP
0876808 Nov 1998 EP
0895762 Feb 1999 EP
0898944 Mar 1999 EP
1017415 Jul 2000 EP
1036545 Sep 2000 EP
1052319 Nov 2000 EP
1055757 Nov 2000 EP
1090590 Apr 2001 EP
1216717 Jun 2002 EP
1216718 Jun 2002 EP
0693523 Nov 2002 EP
1273312 Jan 2003 EP
1315468 Jun 2003 EP
1382728 Jan 2004 EP
1484070 Dec 2004 EP
1561480 Aug 2005 EP
1645232 Apr 2006 EP
1674048 Jun 2006 EP
1691606 Aug 2006 EP
1782848 May 2007 EP
2229918 Sep 2010 EP
2244853 Apr 1975 FR
2257262 Aug 1975 FR
2308349 Nov 1976 FR
2453231 Oct 1980 FR
2612392 Sep 1988 FR
2715309 Jul 1995 FR
2715405 Jul 1995 FR
2724563 Mar 1996 FR
2730406 Aug 1996 FR
2744906 Aug 1997 FR
2766698 Feb 1999 FR
2771622 Jun 1999 FR
2773057 Jul 1999 FR
2774277 Aug 1999 FR
2779937 Dec 1999 FR
2859624 Dec 2005 FR
2876020 Apr 2006 FR
2863277 Jun 2006 FR
2884706 Apr 2008 FR
2929834 Oct 2009 FR
2951069 Apr 2011 FR
2953709 Jun 2011 FR
1174814 Dec 1969 GB
2051153 Jan 1981 GB
2306110 Apr 1997 GB
H0332677 Mar 1991 JP
H05237128 Sep 1993 JP
H09137380 May 1997 JP
H11146888 Jun 1999 JP
2008538300 Oct 2008 JP
2010508121 Mar 2010 JP
2011078767 Apr 2011 JP
8902445 Mar 1989 WO
8908467 Sep 1989 WO
9012551 Nov 1990 WO
9206639 Apr 1992 WO
9220349 Nov 1992 WO
9307321 Apr 1993 WO
9311805 Jun 1993 WO
9318174 Sep 1993 WO
9417747 Aug 1994 WO
9507666 Mar 1995 WO
9518638 Jul 1995 WO
9532687 Dec 1995 WO
9603091 Feb 1996 WO
9608277 Mar 1996 WO
9609795 Apr 1996 WO
9614805 May 1996 WO
9641588 Dec 1996 WO
9735533 Oct 1997 WO
9831345 Jul 1998 WO
9835632 Aug 1998 WO
9849967 Nov 1998 WO
9905990 Feb 1999 WO
9906079 Feb 1999 WO
9906080 Feb 1999 WO
9951163 Oct 1999 WO
0016821 Mar 2000 WO
0067663 Nov 2000 WO
0115625 Mar 2001 WO
0180773 Nov 2001 WO
0181667 Nov 2001 WO
0207648 Jan 2002 WO
0217853 Mar 2002 WO
02078568 Oct 2002 WO
03002168 Jan 2003 WO
2004004600 Jan 2004 WO
2004071349 Aug 2004 WO
2004078120 Sep 2004 WO
2004103212 Dec 2004 WO
2005011280 Feb 2005 WO
2005013863 Feb 2005 WO
2005018698 Mar 2005 WO
2005048708 Jun 2005 WO
2005105172 Nov 2005 WO
2006018552 Feb 2006 WO
2006023444 Mar 2006 WO
2006040760 Apr 2006 WO
2009071998 Jun 2009 WO
2009031035 Jan 2010 WO
2010043978 Apr 2010 WO
2010043980 Apr 2010 WO
2007048099 Sep 2010 WO
2011007062 Jan 2011 WO
2011026987 Mar 2011 WO
2011038740 Apr 2011 WO
Non-Patent Literature Citations (32)
Entry
“A Basic Explanation of Grain Lines,” Fabrics and Textiles, Patternmaking, Sewing and Construction; Feb. 11, 2011 (https://www.thecuttingclass.com/grainlines) (Year: 2011).
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003.
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4).
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6).
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1).
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004.
Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506.
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25.
Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany.
Haneji, K et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009.
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4).
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5).
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19.
International Search Report issued in corresponding application No. PCT/EP2012/062672, dated Sep. 4, 2012.
Japanese Office Action dated May 2, 2016 in corresponding Japanese Patent Application No. 2014-519494, together with English translation, 9 pages.
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26.
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle, ” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3).
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165.
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63.
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7).
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4).
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36.
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10.
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2).
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136.
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34.
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007.
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220, 18(2).
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2.
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299.
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5.
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215, 126(3).
Related Publications (1)
Number Date Country
20210298887 A1 Sep 2021 US
Divisions (1)
Number Date Country
Parent 16927735 Jul 2020 US
Child 17343671 US
Continuations (2)
Number Date Country
Parent 15963523 Apr 2018 US
Child 16927735 US
Parent 14232378 US
Child 15963523 US